Thermo Fisher forges $1.7 billion deal to buy a contract player in the booming gene therapy field
Thermo Fisher is snapping up one of the newborn contract players in the burgeoning gene therapy field.
The company announced late Sunday night that they …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
